
Patients receiving long-term zzso therapy are at increased risk of zzso zzso morbidity and mortality compared with zzso zzso Despite zzso zzso treatment, inflammation remains elevated and zzso count often remains low, with both measures predicting zzso zzso Several factors likely contribute to persistent inflammation and zzso gains during zzso These include residual zzso zzso persistent virus zzso loss of zzso cells, collagen deposition, microbial zzso chronic zzso and zzso zzso How these factors influence disease outcomes and how chronic inflammation should be managed during therapy are the focus of intense ongoing zzso Currently, the most practical advice is to start zzso therapy early and to manage traditional risk factors for zzso conditions zzso This article summarizes a presentation made by Steven zzso zzso MD, at the International AIDS zzso continuing medical education program in Chicago in May zzso 

